BRPI0920984A2 - Método para reduzir trombocitopenia e trombocitopenia associada à mortalidade. - Google Patents
Método para reduzir trombocitopenia e trombocitopenia associada à mortalidade.Info
- Publication number
- BRPI0920984A2 BRPI0920984A2 BRPI0920984A BRPI0920984A BRPI0920984A2 BR PI0920984 A2 BRPI0920984 A2 BR PI0920984A2 BR PI0920984 A BRPI0920984 A BR PI0920984A BR PI0920984 A BRPI0920984 A BR PI0920984A BR PI0920984 A2 BRPI0920984 A2 BR PI0920984A2
- Authority
- BR
- Brazil
- Prior art keywords
- thrombocytopenia
- mortality
- reduce
- risk
- reducing
- Prior art date
Links
- 206010043554 thrombocytopenia Diseases 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
- 230000003582 thrombocytopenic effect Effects 0.000 abstract 1
- COKMIXFXJJXBQG-NRFANRHFSA-N tirofiban Chemical compound C1=CC(C[C@H](NS(=O)(=O)CCCC)C(O)=O)=CC=C1OCCCCC1CCNCC1 COKMIXFXJJXBQG-NRFANRHFSA-N 0.000 abstract 1
- 229960003425 tirofiban Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
MÉTODO PARA REDUZIR TROMBOCITOPENIA E TROMBOCITOPENIA ASSOCIADA À MORTALIDADE. A presente invenção refere-se a métodos para reduzir o risco de mortalidade e morbidez associadas à trombocitopenia, e para reduzir o risco de se tornar trombocitopênico, em pacientes cujo tratamento requer inibição de agregação de plaquetas. Os métodos envolvem a administração de um sal de tirofiban farmaceuticamente aceitável.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11697608P | 2008-11-21 | 2008-11-21 | |
| PCT/US2009/006240 WO2010059244A2 (en) | 2008-11-21 | 2009-11-20 | Method for reducing thrombocytopenia and thrombocytopenia-associated mortality |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0920984A2 true BRPI0920984A2 (pt) | 2017-07-11 |
Family
ID=42198725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0920984A BRPI0920984A2 (pt) | 2008-11-21 | 2009-11-20 | Método para reduzir trombocitopenia e trombocitopenia associada à mortalidade. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20120059036A1 (pt) |
| EP (1) | EP2355824A4 (pt) |
| KR (1) | KR20110108330A (pt) |
| AU (1) | AU2009318101A1 (pt) |
| BR (1) | BRPI0920984A2 (pt) |
| CL (1) | CL2011001175A1 (pt) |
| CO (1) | CO6390039A2 (pt) |
| CR (1) | CR20110271A (pt) |
| DO (1) | DOP2011000149A (pt) |
| EC (1) | ECSP11011152A (pt) |
| MA (1) | MA32820B1 (pt) |
| MX (1) | MX2011005376A (pt) |
| NI (1) | NI201100101A (pt) |
| PE (1) | PE20110946A1 (pt) |
| SV (1) | SV2011003915A (pt) |
| TN (1) | TN2011000256A1 (pt) |
| WO (1) | WO2010059244A2 (pt) |
| ZA (1) | ZA201103741B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101996880B1 (ko) | 2018-03-16 | 2019-07-05 | 경성대학교 산학협력단 | 컴파운드 k를 유효성분으로 포함하는 혈소판 감소증 예방 또는 치료용 조성물 |
| CN112441962A (zh) * | 2019-09-04 | 2021-03-05 | 武汉武药科技有限公司 | 替罗非班及其纯化方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ239846A (en) | 1990-09-27 | 1994-11-25 | Merck & Co Inc | Sulphonamide derivatives and pharmaceutical compositions thereof |
| KR20080067717A (ko) * | 2001-01-26 | 2008-07-21 | 쉐링 코포레이션 | 스테롤 흡수 억제제와 혈액 조절제를 포함하는 혈관 질환의치료 또는 예방용 약제학적 조성물 |
| US6770660B2 (en) | 2002-05-06 | 2004-08-03 | Artery Llc | Method for inhibiting platelet aggregation |
| SI1400245T1 (sl) * | 2002-09-09 | 2006-10-31 | Trigen Ltd | Soli boronske kisline, uporabne v parenteralnih formulacijah za selektivno inhibiranje trombina |
| ES2340179T3 (es) * | 2004-05-12 | 2010-05-31 | Bristol-Myers Squibb Company | Antagonistas de urea del receptor p2y1 utiles en el tratamiento de afecciones tromboticas. |
| KR20070091607A (ko) * | 2004-10-12 | 2007-09-11 | 디코드 제네틱스, 아이엔씨. | 폐쇄성 동맥 질환용의 설폰아미드 주변 치환된바이사이클릭 화합물 |
-
2009
- 2009-11-20 US US13/130,340 patent/US20120059036A1/en not_active Abandoned
- 2009-11-20 PE PE2011001062A patent/PE20110946A1/es not_active Application Discontinuation
- 2009-11-20 AU AU2009318101A patent/AU2009318101A1/en not_active Abandoned
- 2009-11-20 KR KR1020117011598A patent/KR20110108330A/ko not_active Ceased
- 2009-11-20 EP EP09827893A patent/EP2355824A4/en not_active Withdrawn
- 2009-11-20 BR BRPI0920984A patent/BRPI0920984A2/pt not_active IP Right Cessation
- 2009-11-20 WO PCT/US2009/006240 patent/WO2010059244A2/en not_active Ceased
- 2009-11-20 MX MX2011005376A patent/MX2011005376A/es not_active Application Discontinuation
-
2011
- 2011-05-19 CL CL2011001175A patent/CL2011001175A1/es unknown
- 2011-05-20 NI NI201100101A patent/NI201100101A/es unknown
- 2011-05-20 DO DO2011000149A patent/DOP2011000149A/es unknown
- 2011-05-20 TN TN2011000256A patent/TN2011000256A1/fr unknown
- 2011-05-20 MA MA33876A patent/MA32820B1/fr unknown
- 2011-05-20 ZA ZA2011/03741A patent/ZA201103741B/en unknown
- 2011-05-23 SV SV2011003915A patent/SV2011003915A/es unknown
- 2011-05-23 CR CR20110271A patent/CR20110271A/es not_active Application Discontinuation
- 2011-06-14 CO CO11073669A patent/CO6390039A2/es not_active Application Discontinuation
- 2011-06-20 EC EC2011011152A patent/ECSP11011152A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009318101A1 (en) | 2010-05-27 |
| MA32820B1 (fr) | 2011-11-01 |
| CL2011001175A1 (es) | 2011-11-11 |
| WO2010059244A3 (en) | 2010-10-14 |
| NI201100101A (es) | 2011-12-19 |
| EP2355824A2 (en) | 2011-08-17 |
| CO6390039A2 (es) | 2012-02-29 |
| ZA201103741B (en) | 2012-01-25 |
| MX2011005376A (es) | 2011-10-19 |
| KR20110108330A (ko) | 2011-10-05 |
| WO2010059244A2 (en) | 2010-05-27 |
| PE20110946A1 (es) | 2012-01-05 |
| SV2011003915A (es) | 2011-07-01 |
| DOP2011000149A (es) | 2011-10-31 |
| TN2011000256A1 (en) | 2012-12-17 |
| EP2355824A4 (en) | 2012-11-07 |
| US20120059036A1 (en) | 2012-03-08 |
| CR20110271A (es) | 2011-10-13 |
| ECSP11011152A (es) | 2011-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2013001602A1 (es) | Metodo para reducir o inhibir la progresion del nivel de fatiga en pacientes con esclerosis multiple y para proporcionarles neuroproteccion que comprende administrar oralmente laquinimod o una sal del mismo; laquinimod para reducir el nivel de fatiga, mejorar el estado funcional y entregar neuroproteccion en esclerosis multiple. | |
| BR112015018438A2 (pt) | anticorpo contra c5 e método para prevenir e tratar doenças relacionadas a complemento | |
| MX2015014512A (es) | Composicion farmaceutica, metodos para tratamiento y sus usos. | |
| UA117451C2 (uk) | Терапевтично активні сполуки і способи їх застосування | |
| CR20150337A (es) | Derivados de pirimidinona y su uso en el tratamiento, mejora o prevencion de una enfermedad viral | |
| BR112016000546A2 (pt) | métodos para tratar ou prevenir condições oftalmológicas | |
| BR112013024574A2 (pt) | polipeptídeo, uso, método de tratamento de indivíduos portadores de doenças e método de tratamento de indivíduos que possuem doenças com um polipeptídeo | |
| BR112015020466A8 (pt) | inibidores de cdc7, seus usos, e composição farmacêutica | |
| NI201400111A (es) | Tratamiento del cáncer con inhibidores tor cinasa | |
| BR112015005369A2 (pt) | inibidores de usp30 e métodos para sua utilização | |
| BR112014011481A2 (pt) | hidrolisado de colágeno e seu uso | |
| GT201400050A (es) | Derivados de anilina, su preparación y su aplicación terapéutica | |
| BR112016004118A2 (pt) | uso de inibidores da acetil-coa carboxilase para tratamento de acne vulgar | |
| EA201390616A1 (ru) | ЛЕЧЕНИЕ НАРУШЕНИЙ, АССОЦИИРОВАННЫХ С ГЕНОМ MeCP2 | |
| BR112015031417A2 (pt) | forma de dosagem farmacêutica, composição farmacêutica, métodos para tratamento de um paciente com necessidade de cisteamina e para preparo de uma forma de dosagem | |
| AR086422A1 (es) | Metodo para el tratamiento de tumores solidos avanzados, volasertib | |
| BR112013033051A2 (pt) | roda dentada com endentação inclinada e segmento para uma roda dentada | |
| CL2016001546A1 (es) | Composición para el cuidado oral que comprende serina y al menos una sal de zinc. | |
| BR112015021480A2 (pt) | soluções de hidromorfona intratecais tendo estabi-lidade melhorada | |
| MX374220B (es) | Nepentesina para usarse en el tratamiento de la intolerancia al gluten y padecimientos relacionados. | |
| EA201690327A1 (ru) | Терапевтические способы | |
| UY33453A (es) | Método para el tratamiento de la hipertensión pulmonar mediante el uso de ranozalina | |
| AR095594A1 (es) | Métodos para tratar infecciones en pacientes con sobrepeso y obesos usando antibióticos | |
| EA201490041A1 (ru) | Пластырь, содержащий диклофенак и тиоколхикозид | |
| BR112014000889A2 (pt) | tratamento para hipoxia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |